InVivo Therapeutics is a research and clinical-stage biotechnology company focused on the development of technologies for the treatment of spinal cord injuries ... of a stem cell–Neuro-Spinal ...

“This type of cellular therapy ... the differentiation of stem cells over time is “impressive,” as is their ability to make connections in the monkeys’ central nervous systems, but more work needs to ...

Over the past two decades, exosomes—small, extracellular vesicles that are naturally released by many cell types and ... regeneration for the treatment of acute spinal cord injuries.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Neural stem cell transplantation is an emerging treatment for various neurological ... cell transplantation for chronic thoracic spinal cord injury, Cell Reports Medicine (2024).

which followed four patients with chronic spinal cord injuries for five years, found that two patients showed durable evidence of neurological improvement after treatment with neural stem cell ...

Three of the four patients were deemed by examiners to have very slight improvements in sensation and muscle movement. Severe spinal injuries can have devastating consequences, often leaving patients ...

New research highlights the promise of a novel stem cell treatment strategy for leptomeningeal ... to membranes surrounding the brain and spinal cord and occurs in up to 20% of people with cancer.

Multiple babies have been born after receiving the world’s first spina bifida treatment ... The stem cell patch was placed directly over the exposed spinal cord of the fetus.

Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...